8-K - ORIC Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. On May 6, 2021, ORIC Pharmaceuticals, Inc. (the “Company”) entered into an Open Market Sale Agreement SM (the “Sales Agreement”) with Jefferies LL

Other Event

$200.0M$139.7M$200.0M

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 5.1 Opinion of Wilson Sonsini Goodrich & Rosati, P.C. 23.1 Consent of Wilson Sonsini

Exhibits Only

Exhibits (2)

5.1

EX-5.1

8-K